Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Postoperative, Cardiac-Sparing Proton Radiotherapy for Patients With Stage II/III,Loco-Regional, Non-Metastatic Breast Cancer Requiring Whole Breast or Chest Wall Irradiation With Lymph Node Irradiation

NCT01758445 is registered in ClinicalTrials.gov with Proton Collaborative Group as lead sponsor.

NCT NCT01758445
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01758445 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Postoperative, Cardiac-Sparing Proton Radiotherapy for Patients With Stage II/III,Loco-Regional, Non-Metastatic Breast Cancer Requiring Whole Breast or Chest Wall Irradiation With Lymph Node Irradiation
Lead sponsor
Proton Collaborative Group
Phase
Phase 2
Overall status
Active, not recruiting
Start date
February 28, 2013
Completion date
January 31, 2032
Enrollment
220 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, breast neoplasm, breast tumor, cancer of the breast